108937 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses
RNA-guided human genome engineering
#2402Artificial genome manipulation for gene expression regulation
#2403MODEL EDITING SYSTEMS AND METHODS RELATING TO THE SAME
#2404CURING FOR RECURSIVE NUCLEIC ACID-GUIDED CELL EDITING
#2405CRISPR-CAS BASED SYSTEM FOR TARGETING SINGLE-STRANDED SEQUENCES
#2406Targeted Sequence Insertion Compositions and Methods
#2407CAS9 PROTEIN FOR GENOME EDITING
#2408Engineered meganucleases that target human mitochondrial genomes
#2409Compositions comprising a variant Cas12i4 polypeptide and uses thereof
#2410METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE BASED ON HOST-MYCOBIOTA INTERACTIONS
#2411Compositions and Methods for Kallikrein (KLKB1) Gene Editing
#2412TARGETED DISRUPTION OF T CELL AND/OR HLA RECEPTORS
#2413LASER-ACTUATED SUPERCRITICAL INJECTOR
#2414GENE EDITING-BASED METHOD OF ATTENUATING THE BETA-AMYLOID PATHWAY
#2415Gene therapy for haploinsufficiency
#2416COMPOSITION AND METHOD FOR INHIBITING PROLIFERATION HEPATITIS B VIRUS
#2417PRECISE BREEDING METHODS FOR GENE-EDITED NON-HUMAN ANIMALS
#2418PLATFORM FOR EXPRESSING PROTEIN OF INTEREST IN LIVER
#2419MAMMALIAN CELLS COMPRISING INTEGRATED CAS9 GENES TO PRODUCE STABLE INTEGRATION SITES, AND MAMMALIAN CELLS COMPRISING STABLE INTEGRATION SITES AND OTHER SITES
#2420SINGLE GENERATION TARGETED GENE INTEGRATION
#2421TYPE I-C CRISPR SYSTEM FROM NEISSERIA LACTAMICA AND METHODS OF USE
#2422COMPOSITIONS COMPRISING A CAS12I POLYPEPTIDE AND USES THEREOF
#2423SEQUENTIAL GENE EDITING IN PRIMARY IMMUNE CELLS
#2424PROGRAMMABLE INSERTION APPROACHES VIA REVERSE TRANSCRIPTASE RECRUITMENT
#2425GUIDE-RNA EXPRESSION SYSTEM FOR A HOST CELL
#2426Compositions comprising a variant polypeptide and uses thereof
#2427RNA GUIDED COMPOSITIONS FOR PREVENTING AND TREATING HEPATITIS B VIRUS INFECTIONS
#2428Modified guide RNAs
#2429KRAB FUSION REPRESSORS AND METHODS AND COMPOSITIONS FOR REPRESSING GENE EXPRESSION
#2430CRISPR/CAS FUSION PROTEINS AND SYSTEMS
#2431IMMOBILIZED ENZYME COMPOSITIONS AND METHODS
#2432CRISPR-Cas effector polypeptides and methods of use thereof
#2433Targeted DNA demethylation method, fusion protein and application thereof preliminary class
#2434Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation
#2435NOVEL, NON-NATURALLY OCCURRING CRISPR-CAS NUCLEASES FOR GENOME EDITING
#2436SEQUENCE SPECIFIC DEGRADATION OF SINGLE-STRANDED POLYNUCLEOTIDES WITH CARD1 NUCLEASE
#2437NOVEL CAS ENZYMES AND METHODS OF PROFILING SPECIFICITY AND ACTIVITY
#2438A NEW, NON-SPECIFIC THERMOLABILE NUCLEASE ACTIVE AT LOW TEMPERATURE, IN WIDE PH RANGE AND HIGH CONCENTRATION IN SALTS
#2439CRISPR-CAS SYSTEM FOR GENE THERAPY
#2440MATERIALS AND METHODS FOR MAKING SEXUAL STAGE PLASMODIUM PARASITES
#2441SUPPRESSION OF SHADE AVOIDANCE RESPONSE IN PLANTS
#2442CAS9 PROTEINS INCLUDING LIGAND-DEPENDENT INTEINS
#2443ENGINEERED CAS9-NUCLEASES AND METHOD OF USE THEREOF
#2444GENOMIC SAFE HARBORS FOR GENETIC THERAPIES IN HUMAN STEM CELLS AND ENGINEERED NANOPARTICLES TO PROVIDE TARGETED GENETIC THERAPIES
#2445MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS
#2446BASE EDITING APPROACHES FOR THE TREATMENT OF BETAHEMOGLOBINOPATHIES
#2447MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION
#2448GENE EDITED SOYBEAN PLANTS WITH ENHANCED TRAITS
#2449Repressible control of gene expression
#2450Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
#2451Sequence-Specific Targeted Transposition and Selection and Sorting of Nucleic Acids
#2452Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions
#2453SIGNAL BOOST CASCADE ASSAY
#2454Modified CAS9 protein, and use thereof
#2455NOVEL CRISPR ENZYMES, METHODS, SYSTEMS AND USES THEREOF
#2456DETERGENT COMPOSITIONS CONTAINING ENZYMES
#2457Methods of Prevention or Treatment of Alzheimer's Disease by Blocking or Decreasing STING Signaling Activation
#2458CHIMERIC RECEPTOR BINDING PROTEINS FOR USE IN BACTERIAL DELIVERY VEHICLES
#2459DETECTION ASSAYS
#2460DISCOVERY AND ENGINEERING OF INTEGRASES FOR HIGH-EFFICIENCY GENE INTEGRATION
#2461GENOMIC EDITING WITH SITE-SPECIFIC RETROTRANSPOSONS
#2462Enhancing Utrophin Expression in Cell by Inducing Mutations Within Utrophin Regulatory Elements and Therapeutic Use Thereof
#2463COMPOSITIONS OF DNA MOLECULES, METHODS OF MAKING THEREFOR, AND METHODS OF USE THEREOF
#2464METHODS AND COMPOSITIONS FOR EDITING THE B2M LOCUS IN B CELLS
#2465METHODS AND COMPOSITIONS FOR MODULATING A GENOME
#2466MODIFICATION OF BLOOD TYPE ANTIGENS
#2467METHODS AND COMPOSITIONS FOR CORRECTION OF DMD MUTATIONS
#2468METHODS AND COMPOSITIONS FOR EVOLVING BASE EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
#2469GENETIC MODIFICATION OF CYTOKINE INDUCIBLE SH2-CONTAINING PROTEIN (CISH) GENE
#2470PLASTID TRANSFORMATION BY COMPLEMENTATION OF PLASTID MUTATIONS
#2471Polypeptides useful for gene editing and methods of use
#2472METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163
#2473RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
#2474Engineered Guide RNA Sequences for In Situ Detection and Sequencing
#2475ENRICHMENT OF MUTATED CELL FREE NUCLEIC ACIDS FOR CANCER DETECTION
#2476METHODS OF GENOME EDITING INCLUDING CONTROLLED OPENING OF CHROMATIN
#2477ENHANCED hAT FAMILY MEMBER SPIN TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
#2478Stabilized Nucleic Acids Encoding Messenger Ribonucleic Acid (mRNA)
#2479Inhibitors of the Artemin Pathway for Treatment of Cancer
#2480COMPOSITIONS AND METHODS COMPRISING PLANTS WITH MODIFIED ANTHOCYANIN CONTENT
#2481HETEROZYGOUS CENH3 MONOCOTS AND METHODS OF USE THEREOF FOR HAPLOID INDUCTION AND SIMULTANEOUS GENOME EDITING
#2482COLOR-BASED AND/OR VISUAL METHODS FOR IDENTIFYING THE PRESENCE OF A TRANSGENE AND COMPOSITIONS AND CONSTRUCTS RELATING TO THE SAME
#2483Compositions and methods for targeting, editing, or modifying genes
#2484A MODULAR AND POOLED APPROACH FOR MULTIPLEXED CRISPR GENOME EDITING
#2485CANNABIS WITH ALTERED CANNABINOID CONTENT
#2486REMOVABLE PLANT TRANSGENIC LOCI WITH COGNATE GUIDE RNA RECOGNITION SITES
#2487INCORPORATION OF INTERNAL POLYA-ENCODED POLY-LYSINE SEQUENCE TAGS AND THEIR VARIATIONS FOR THE TUNABLE CONTROL OF PROTEIN SYNTHESIS IN BACTERIAL AND EUKARYOTIC CELLS
#2488Type II CRISPR/Cas9 genome editing system and the application thereof
#2489CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS AND METHODS OF USE THEREOF
#2490ENGINEERED NUCLEASES AND METHODS OF USE THEREOF
#2491ENGINEERED MAD7 DIRECTED ENDONUCLEASE
#2492Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
#2493Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) Inhibitors
#2494Encoded Dual-Probe Endonuclease Assays
#2495ENZYMATIC OLIGONUCLEOTIDE ASSEMBLY USING HAIRPINS AND ENZYMATIC CLEAVAGE
#2496Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing
#2497Inducible CRISPR system expression and applications thereof
#2498GENE EDITING TO IMPROVE JOINT FUNCTION
#2499PLANT METABOLITE-MEDIATED INDUCTION OF BIOFILM FORMATION IN SOIL BACTERIA TO INCREASE BIOLOGICAL NITROGEN FIXATION AND PLANT NITROGEN ASSIMILATION
#2500Compositions and methods for TTR gene editing and treating ATTR amyloidosis
#2501RNA-guided nucleases and active fragments and variants thereof and methods of use
#2502EFFECTOR PROTEINS AND METHODS OF USE
#2503COMPOSITIONS AND METHODS FOR DIRECTING PROTEINS TO SPECIFIC LOCI IN THE GENOME
#2504NON-STANDARD AMINO ACID CONTAINING COMPOSITIONS AND USES THEREOF
#2505CRISPR/CAS9 THERAPIES FOR CORRECTING DUCHENNE MUSCULAR DYSTROPHY BY TARGETED GENOMIC INTEGRATION
#2506Nucleases for genome editing
#2507CULTURE OF ORGANOIDS
#2508GENE EDITING FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA
#2509MULTIPLEX NUCLEIC ACID DETECTION SYSTEM
#2510HOMOGENOUS ASSAYS IN MICRODROPLETS
#2511Transposition-based therapies
#2512TRANSPOSITION-BASED THERAPIES
#2513UNIVERSAL DONOR CELLS
#2514INHT26 TRANSGENIC SOYBEAN
#2515Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors
#2516GENOME EDITING OF HUMAN NEURAL STEM CELLS USING NUCLEASES
#2517COMPOSITIONS, METHODS, MODULES AND INSTRUMENTS FOR AUTOMATED NUCLEIC ACID-GUIDED NUCLEASE EDITING IN MAMMALIAN CELLS USING MICROCARRIERS
#2518SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES
#2519T-CELLS EXPRESSING IMMUNE CELL ENGAGERS IN ALLOGENIC SETTINGS
#2520METHOD FOR TREATING ALZHEIMER'S DISEASE BY TARGETING MAPT GENE
#2521SUPRAMOLECULAR NANOSUBSTRATE-MEDIATED DELIVERY SYSTEM ENABLES CRISPR/CAS9 KNOCKIN OF HEMOGLOBIN BETA GENE-A POTENTIAL THERAPEUTIC SOLUTION FOR HEMOGLOBINOPATHIES
#2522Systems and Methods for Stable and Heritable Alteration by Precision Editing (SHAPE)
#2523FLUORESCENT CROSS-LINKED RNASE H MUTANT CONJUGATE, MIRNA COMBINATION AND APPLICATION THEREOF
#2524COMPOSITIONS FOR EXPOSING FILM-FORMING MICROBES AND METHODS FOR USE OF THE COMPOSITIONS
#2525METHODS AND PRODUCTS FOR TRANSFECTING CELLS
#2526DUAL PROMOTER SYSTEMS
#2527METHOD FOR INCREASING METHIONINE CONTENT IN GRAINS BY GENE KNOCKOUT
#2528Compositions and methods for modifying genomes
#2529GENE EDITING TOOLS
#2530METHODS AND COMPOSITIONS FOR MODULATING A GENOME
#2531NOVEL TRANSPLANTATION CELLS HAVING REDUCED IMMUNOGENICITY
#2532NOVEL TYPE I-C CRISPR-CAS SYSTEM FROM CLOSTRIDIA
#2533CRISPR DNA and RNA targeting enzymes and systems
#2534COMPOSITIONS AND METHODS FOR ENGRAFTMENT OF BASE EDITED CELLS
#2535COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS
#2536NUCLEIC ACID-GUIDED EDITING OF EXOGENOUS POLYNUCLEOTIDES IN HETEROLOGOUS CELLS
#2537ISCAN: AN RT-LAMP-COUPLED CRISPR-CAS MODULE FOR RAPID, SENSITIVE DETECTION OF SARS-COV-2
#2538Compositions of matter for detection assays
#2539Engineered retrons and methods of use
#2540METHODS AND MEANS FOR GENETIC ALTERATION OF GENOMES UTILIZING DESIGNER DNA RECOMBINING ENZYMES
#2541CRISPR SYSTEMS WITH ENGINEERED DUAL GUIDE NUCLEIC ACIDS
#2542Compositions and methods for targeting, editing, or modifying genes
#2543METHOD OF CONTAINMENT OF NUCLEIC ACID VECTORS INTRODUCED IN A MICROBIOME POPULATION
#2544RNA-guided nucleases and active fragments and variants thereof and methods of use
#2545HOST DEFENSE SUPPRESSING METHODS AND COMPOSITIONS FOR MODULATING A GENOME
#2546COMPOSITIONS AND METHODS FOR ALTERING PLANT DETERMINACY
#2547PLANT CELL TREATMENTS TO IMPROVE PLANT TRANSFORMATION
#2548METHODS FOR PRODUCING A COMPLEX TRANSGENIC TRAIT LOCUS
#2549Gene Editing System of Escherichia Coli and Gene Editing Method Thereof
#2550CIRCULAR RNA PLATFORMS, USES THEREOF, AND THEIR MANUFACTURING PROCESSES FROM ENGINEERED DNA
#2551Compositions and Methods for Treating Huntington's Disease and Related Disorders
#2552GENE EDITING TO IMPROVE JOINT FUNCTION
#2553DIRECTED EVOLUTION METHOD BASED ON PRIMARY AND SECONDARY REPLICON OF GEMINI VIRUS
#2554ARGONAUTE PROTEIN FROM EUKARYOTES AND APPLICATION THEREOF
#2555CELLS MODIFIED BY A CAS12I POLYPEPTIDE
#2556COMPOSITIONS COMPRISING A CRISPR NUCLEASE AND USES THEREOF
#2557TARGETING BCL11A ENHANCER FUNCTIONAL REGIONS FOR FETAL HEMOGLOBIN REINDUCTION
#2558MATERIALS AND METHODS FOR TREATMENT OF TITIN-BASED MYOPATHIES AND OTHER TITINOPATHIES
#2559LIGHT-INDUCIBLE GENE ACTIVATION SYSTEMS AND METHODS FOR MAKING AND USING THEM
#2560Compositions and Methods for Suppressing MSUT2
#2561COMPOSITIONS AND METHODS FOR THE IMPROVED PRODUCTION AND DELIVERY OF RNA BY EFFICIENT TRANSCRIPTION TERMINATION
#2562METHOD FOR PRODUCING AN ANIMAL COMPRISING A GERMLINE GENETIC MODIFICATION
#2563METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2564CLASS II, TYPE V CRISPR SYSTEMS
#2565SELECTION BY ESSENTIAL-GENE KNOCK-IN
#2566Materials and Methods for Treatment of Myotonic Dystrophy Type 1 (DM) and Other Related Disorders
#2567METHOD FOR BASE EDITING IN PLANTS
#2568Enhanced virus-like particles and methods of use thereof for delivery to cells
#2569Transcriptional control in prokaryotic cells using DNA-binding repressors
#2570ENHANCED PURIFICATION OF ADENO-ASSOCIATED VIRUS TO MORE EFFECTIVELY REMOVE CONTAMINATING DNA
#2571GENETICALLY MODIFIED NON-HUMAN ANIMAL EXPRESSING A B2M/FCRN FUSION PROTEIN
#2572ELIMINATION OF COLONIC BACTERIAL DRIVING LETHAL INFLAMMATORY CARDIOMYOPATHY
#2573METHOD FOR REJUVENATING GLIAL PROGENITOR CELLS AND REJUVENATED GLIAL PROGENITOR CELLS PER SE
#2574COMPOSISTIONS AND METHODS FOR CRISPR ENABLED DNA SYNTHESIS
#2575PAM-REDUCED AND PAM-ABOLISHED CAS DERIVATIVES COMPOSITIONS AND USES THEREOF IN GENETIC MODULATION
#2576RAPID REMOVAL OF A SELF-REPLICATING FUNGAL PLASMID FOR EFFICIENT MARKER CYCLING
#2577ALTERATION OF SEED COMPOSITION IN PLANTS
#2578Lettuce with increased shelf life
#2579PRECISE INTRODUCTION OF DNA OR MUTATIONS INTO THE GENOME OF WHEAT
#2580GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY
#2581HIGH PURITY gRNA SYNTHESIS PROCESS
#2582Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
#2583CRISPR-CAS9 MEDIATED DISRUPTION OF ALCAM GENE INHIBITS ADHESION AND TRANS-ENDOTHELIAL MIGRATION OF MYELOID CELLS
#2584GRNA TARGETING CTGF GENE AND USE THEREOF
#2585METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA DIRECTED MODULATION OF TRANSCRIPTION
#2586METHODS FOR TARGETED INSERTION OF EXOGENOUS SEQUENCES IN CELLULAR GENOMES
#2587GENOME EDITING SYSTEM AND METHOD
#2588METHODS AND COMPOSITIONS FOR EFFICIENT AND PRECISE GENE EDITING IN MAMMALIAN BRAIN TO PREVENT OR TREAT NERVOUS SYSTEM DISORDERS
#2589METHODS FOR CONTROLLING MERISTEM SIZE FOR CROP IMPROVEMENT
#2590Generation of site specific integration sites for complex trait loci in corn and soybean, and methods of use
#2591Methods and Systems of Molecular Recording by Crispr-Cas System
#2592CRISPR DNA targeting enzymes and systems
#2593Gene editing systems comprising an RNA guide targeting hydroxyacid oxidase 1 (HAO1) and uses thereof
#2594Gene editing systems comprising an RNA guide targeting lactate dehydrogenase a (LDHA) and uses thereof
#2595USE OF A NUCLEASE FOR REDUCING THE VISCOSITY AND/OR PREVENTING AN INCREASE IN VISCOSITY OF A FERMENTATION BROTH
#2596METHODS FOR INTEGRATING DNA INTO GENES WITH GAIN-OF-FUNCTION OR LOSS-OF-FUNCTION MUTATIONS
#2597COMPOSITIONS AND METHODS FOR EPIGENOME EDITING
#2598RNA-Guided Systems for In Vivo Gene Editing
#2599SARS-COV-2-SPECIFIC T CELLS
#2600GENE-EDITED BASIL PLANTS RESISTANT TO DOWNY MILDEW
#2601OPTIMIZED GENE EDITING UTILIZING A RECOMBINANT ENDONUCLEASE SYSTEM
#2602GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING STATHMIN 2 (STMN2) AND USES THEREOF
#2603SYSTEMS AND METHODS FOR CELLULAR REPROGRAMMING OF A PLANT CELL
#2604Modified excisable DAS81419-2 soybean transgenic insect resistance locus
#2605Mutations in Cas9 discovered by broad scanning mutagenesis demonstrate enhancement of DNA cleavage activity
#2606EFFECTOR PROTEINS AND METHODS OF USE
#2607LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS
#2608Method for digesting nucleic acid in a sample
#2609Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing
#2610RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
#2611MODIFIED ENDONUCLEASES AND RELATED METHODS
#2612HYPOIMMUNOGENIC CELLS
#2613TARGETED GENOMIC INTEGRATION TO RESTORE NEUROFIBROMIN CODING SEQUENCE IN NEUROFIBROMATOSIS TYPE 1 (NF1)
#2614CRISPR-MEDIATED GENOME EDITING WITH VECTORS
#2615PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES
#2616Modified excisable MON89034 transgenic maize insect resistance locus
#2617DETERMINATION OF BASE MODIFICATIONS OF NUCLEIC ACIDS
#2618CRISPR HYBRID DNA/RNA POLYNUCLEOTIDES AND METHODS OF USE
#2619CAS9 Fusion Proteins and Related Methods
#2620METHODS FOR INCREASING THE EFFICIENCY OF HOMOLOGY DIRECTED REPAIR (HDR) IN THE CELLULAR GENOME
#2621SELF-LIMITING VIRAL VECTORS ENCODING NUCLEASES
#2622UNIVERSAL DONOR CELLS
#2623Incorporation of unnatural amino acids into proteins using base editing
#2624COMPOSITIONS AND METHODS FOR TREATING FABRY DISEASE
#2625Treatment Of Kidney Diseases With Angiopoietin Like 3 (ANGPTL3) Inhibitors
#2626METHODS AND COMPOSITIONS FOR IMPROVED TYPE I-E CRISPR BASED GENE SILENCING
#2627TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING
#2628SYSTEM AND METHOD FOR GENE EDITING BY USING ENGINEERED CELL
#2629ENZYME REACTION SOLUTION FOR CONSTRUCTING SEQUENCING LIBRARY AND USE THEREOF
#2630IMPROVED HIGH-THROUGHPUT COMBINATORIAL GENETIC MODIFICATION SYSTEM AND OPTIMIZED CAS9 ENZYME VARIANTS
#2631CAS12B SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED DNA BASE EDITING
#2632ENGINEERED GENE-EDITING PROTEINS
#2633TREATMENT OF RETINITIS PIGMENTOSA USING IMPROVED ENGINEERED MEGANUCLEASES
#2634Applications of Recombined ScCas9 Enzymes for PAM-free DNA Modification
#2635UNIVERSAL DONOR CELLS
#2636UNIVERSAL DONOR CELLS
#2637METHODS FOR TREATING GAIN-OF-FUNCTION DISORDERS COMBINING GENE EDITING AND GENE THERAPY
#2638AAV Vector for Disrupting Coagulation Factor-Related Gene on Liver Genome
#2639COMPOSITIONS AND METHODS FOR TREATING AN INHERITED RETINAL DISEASE
#2640GENE EDITING OF ANTICOAGULANT FACTORS
#2641ALTERNATIVE GENERATION OF ALLOGENEIC HUMAN T CELLS
#2642A METHOD FOR CRISPR LIBRARY SCREENING
#2643IMPROVED DETECTION ASSAYS
#2644Systems, methods, and compositions for correction of frameshift mutations
#2645Methods of in Vitro Cell Delivery
#2646COMPLEXES FOR GENE DELETION AND EDITING
#2647HDR ENHANCERS
#2648HDR ENHANCERS
#2649GENETIC PHYSICAL UNCLONABLE FUNCTIONS AND METHODS OF USE THEREOF
#2650METHODS FOR IMPROVING FLORET FERTILITY AND SEED YIELD
#2651Optimized CRISPR-Cas nucleases and base editors and methods of use thereof
#2652MULTI-FUNCTIONAL GSH-RESPONSIVE SILICA NANOPARTICLES FOR DELIVERY OF BIOMOLECULES INTO PLANT CELLS
#2653Particle delivery systems
#2654CRISPR DNA targeting enzymes and systems
#2655MODIFIED GUIDE RNAS FOR NEISSERIA MENINGITIDIS CAS9
#2656CURE ALL FOR NUCLEIC ACID-GUIDED CELL EDITING IN E. COLI
#2657SELF-LIMITING VIRAL VECTORS ENCODING NUCLEASES
#2658ISOLATED CHIMERIC ANTIGEN RECEPTOR, MODIFIED T CELL COMPRISING SAME AND USE THEREOF
#2659Materials and methods for treatment of Duchenne Muscular Dystrophy
#2660METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#2661PHAGE-MEDIATED DELIVERY OF GENES TO GUT MICROBIOME
#2662ANTIBODY GENE EDITING IN B LYMPHOCYTES AND CO-EXPRESSION OF CARGO PROTEIN
#2663COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA
#2664Production of Human Cells, Tissues, and Organs in a Growth Factor Receptor-Deficient Animal Host
#2665Compositions and methods for promoting gene editing of CXCR4 gene
#2666SCALABLE TRIO GUIDE RNA APPROACH FOR INTEGRATION OF LARGE DONOR DNA
#2667RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
#2668IMMUNOSUPPRESSIVE AGENTS AND VIRAL DELIVERY RE-DOSING METHODS FOR GENE THERAPY
#2669COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY
#2670COMPOSITIONS AND METHODS FOR BASE SPECIFIC MITOCHONDRIAL GENE EDITING
#2671A PLANT FERTILITY-ASSOCIATED PROTEIN AND ITS APPLICATION THEREOF
#2672METHODS AND COMPOSITIONS FOR INCREASING RESISTANCE TO EAR ROT AND STEM ROT DISEASE IN MAIZE
#2673GRNA FOR KNOCKING OUT PIG XENOANTIGEN GENE, AND APPLICATION THEREOF
#2674METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#2675SYSTEMS AND METHODS FOR VIRAL GENOME TARGETING
#2676Differential knockout of an allele of a heterozygous bestrophin 1 gene
#2677Assays For Measuring Nucleic Acid Modifying Enzyme Activity
#2678DONOR REPAIR TEMPLATES MULTIPLEX GENOME EDITING
#2679TRANSCRIPTIONAL ROADBLOCKS FOR GENE EDITING AND METHODS OF USING THE SAME
#2680USE OF A DEFICIENT FUSION PROTEIN FOR NUCLEASE ACTIVITY SO AS TO INDUCE MEIOTIC RECOMBINATIONS
#2681PLANT GENOME EDITING TECHNIQUE NOT RELYING ON GENE RECOMBINATION UTILIZING CELL MEMBRANE-PERMEABLE PEPTIDE
#2682CRISPR-INHIBITION FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#2683ENGINEERED CELLS SECRETING THERAPEUTIC ENZYMES
#2684Guide RNA that targets a mutant human inosine monophosphate deyhydrogenase I allele
#2685Guide RNA that targets a mutant human guanylate cyclase 2A allele
#2686DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS RHODOPSIN GENE
#2687METHOD FOR TREATING MUSCULAR DYSTROPHY BY TARGETING LAMA1 GENE
#2688COMPOSITIONS AND METHODS FOR SEQUENTIAL STACKING OF NUCLEIC ACID SEQUENCES INTO A GENOMIC LOCUS
#2689AN ULTRASENSITIVE RAPID AND PORTABLE CASE13D-BASED DIAGNOSTIC ASSAY
#2690CRISPR CASCADE ASSAY
#2691COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY
#2692DESIGN OF TWO-PART GUIDE RNAS FOR CRISPRa APPLICATIONS
#2693Optimised Methods for Cleavage of Target Sequences
#2694Segmented Nucleic Acids
#2695COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN SYNDROME
#2696COMPOSITIONS FOR TREATING CANCER WITH KRAS MUTATIONS AND USES THEREOF
#2697AUTOINDUCER-2 (AI-2) MOLECULAR RESPONSE-BASED STARTING ELEMENT AND ESCHERICHIA COLI (E. COLI) DYNAMIC REGULATION SYSTEM AND METHOD CONSTRUCTED THEREBY
#2698TAGGED GENE EDITING TECHNOLOGY FOR CLINICAL CELL SORTING AND ENRICHMENT
#2699ANTI-CRISPR COMPOUNDS AND METHODS OF USE
#2700RNA GUIDED ERADICATION OF VARICELLA ZOSTER VIRUS